All Stories

  1. Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance
  2. A Scoping Review on Progression Towards Freedom from Peste des Petits Ruminants (PPR) and the Role of the PPR Monitoring and Assessment Tool (PMAT)
  3. Mapping novel antigenic determinants on foot-and-mouth disease virus serotype Asia 1 using neutralising monoclonal antibody resistant mutants
  4. Current Advances in Genetic Detection and Nanopore Sequencing of Peste des Petits Ruminants Virus
  5. PPR Infection Crossing Between Domestic and Wild Hoofed Mammals: Does This Matter for Virus Eradication?
  6. Seroprevalence of peste des petits ruminants in sheep and goats managed under pastoral and agro-pastoral systems
  7. Update on peste des petits ruminants in Europe
  8. Post-Vaccination Sero-Monitoring of Peste des Petits Ruminants in Sheep and Goats in Karnataka: Progress towards PPR Eradication in India
  9. Evaluation of a novel liquid stabilised peste des petits ruminants vaccine: Safety and immunogenic efficacy in sheep and goats in the field in Jordan
  10. The evaluation of five serological assays in determining seroconversion to peste des petits ruminants virus in typical and atypical hosts
  11. Peste Des Petits Ruminants Screening and Diagnostic Tests in African Wildlife in the Context of Rinderpest Eradication (1994–2007)
  12. Towards Eradication of PPR: Disease Status, Economic Cost and Perception of Veterinarians in Karnataka, India
  13. Peste des Petits Ruminants in Central and Eastern Asia/West Eurasia: Epidemiological Situation and Status of Control and Eradication Activities after the First Phase of the PPR Global Eradication Programme (2017–2021)
  14. Development and Evaluation of Molecular Pen-Side Assays without Prior RNA Extraction for Peste des Petits Ruminants (PPR) and Foot and Mouth Disease (FMD)
  15. Retrospective Characterization of Initial Peste des petits ruminants Outbreaks (2008–2012) in the Democratic Republic of the Congo
  16. Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
  17. Development and Evaluation of a Nested PCR for Improved Diagnosis and Genetic Analysis of Peste des Petits Ruminants Virus (PPRV) for Future Use in Nascent PPR Eradication Programme
  18. Ongoing Assessment of the Molecular Evolution of Peste Des Petits Ruminants Virus Continues to Question Viral Origins
  19. Complete Genome Sequencing of Field Isolates of Peste des Petits Ruminants Virus from Tanzania Revealed a High Nucleotide Identity with Lineage III PPR Viruses
  20. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013–2018) from Southeast Asia
  21. Environmental sampling for the detection of foot‐and‐mouth disease virus and peste des petits ruminants virus in a live goat market, Nepal
  22. Development of Nanobodies Targeting Peste des Petits Ruminants Virus: The Prospect in Disease Diagnosis and Therapy
  23. Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations
  24. Peste des Petits Ruminants Virus Infection at the Wildlife–Livestock Interface in the Greater Serengeti Ecosystem, 2015–2019
  25. Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus
  26. Progress towards Eradication of Peste des Petits Ruminants through Vaccination
  27. RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle
  28. Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes
  29. Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection
  30. Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease
  31. Eradication of Peste des Petits Ruminants Virus and the Wildlife-Livestock Interface
  32. Peste des Petits Ruminants at the Wildlife–Livestock Interface in the Northern Albertine Rift and Nile Basin, East Africa
  33. Outbreak of Peste des Petits Ruminants among Critically Endangered Mongolian Saiga and Other Wild Ungulates, Mongolia, 2016–2017
  34. Detection of antibodies against a conserved capsid epitope as the basis of a novel universal serological test for foot-and-mouth disease
  35. Rapid Detection of Peste des Petits Ruminants Virus (PPRV) Nucleic Acid Using a Novel Low-Cost Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Assay for Future Use in Nascent PPR Eradication Programme
  36. Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection
  37. Optimization and evaluation of a non-invasive tool for peste des petits ruminants surveillance and control
  38. Quantifying Levels of Peste Des Petits Ruminants (PPR) Virus in Excretions from Experimentally Infected Goats and Its Importance for Nascent PPR Eradication Programme
  39. Molecular characterization of Peste des petits ruminants viruses in the Marmara Region of Turkey
  40. Detection of foot-and-mouth disease virus in milk samples by real-time reverse transcription polymerase chain reaction: Optimisation and evaluation of a high-throughput screening method with potential for disease surveillance
  41. Monoclonal antibody resistant mutant of Peste des petits ruminants vaccine virus
  42. Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches
  43. Foot and mouth disease vaccine strain selection: current approaches and future perspectives
  44. Molecular detection, isolation and characterization of Peste-des-petits ruminants virus from goat milk from outbreaks in Bangladesh and its implication for eradication strategy
  45. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain
  46. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia, East Asia and Far East
  47. Persistence of Lineage IV Peste-des-petits ruminants virus within Israel since 1993: An evolutionary perspective
  48. Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe
  49. Re-emergence of Peste des Petits Ruminants virus in 2015 in Morocco: Molecular characterization and experimental infection in Alpine goats
  50. Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus
  51. Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions
  52. Spillover of Peste des Petits Ruminants Virus from Domestic to Wild Ruminants in the Serengeti Ecosystem, Tanzania
  53. Peste des petits ruminants
  54. Detection and Genetic Characterization of Lineage IV Peste Des Petits Ruminant Virus in Kazakhstan
  55. Serological Detection of Antibodies to Peste des Petits Ruminants Virus in Large Ruminants
  56. Complete Genome Sequences of Serotype O Foot-and-Mouth Disease Viruses Recovered from Experimental Persistently Infected Cattle
  57. Virus Excretion from Foot-And-Mouth Disease Virus Carrier Cattle and Their Potential Role in Causing New Outbreaks
  58. Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis
  59. Development of a Competitive Enzyme-Linked Immunosorbent Assay for Detection of Antibodies against the 3B Protein of Foot-and-Mouth Disease Virus
  60. Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses
  61. Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccine
  62. Serological profile of foot-and-mouth disease in wildlife populations of West and Central Africa with special reference to Syncerus caffer subspecies
  63. Pathology of Peste des Petits Ruminants
  64. Molecular Epidemiology of Peste des Petits Ruminants Virus
  65. Vaccines Against Peste des Petits Ruminants Virus
  66. Molecular Evolution of Peste des Petits Ruminants Virus
  67. Peste des Petits Ruminants Virus, Eastern Asia
  68. Molecular characterization of peste-des-petits ruminants virus (PPRV) isolated from an outbreak in the Indo-Bangladesh border of Tripura state of North-East India
  69. Emergence of Lineage IV Peste des Petits Ruminants Virus in Ethiopia: Complete Genome Sequence of an Ethiopian Isolate 2010
  70. Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo
  71. Molecular characterisation of lineage IV peste des petits ruminants virus using multi gene sequence data
  72. Complete Genome Sequences of Lineage III Peste des Petits Ruminants Viruses from the Middle East and East Africa
  73. Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains
  74. Transmission of foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact naïve and vaccinated Indian buffalo and cattle
  75. Detection of subclinical peste des petits ruminants virus infection in experimental cattle
  76. Morbillivirus vaccines: Recent successes and future hopes
  77. Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle
  78. Patterns of Foot-and-Mouth Disease Virus Distribution in Africa
  79. Evolutionary genetics underlying the spread of peste des petits ruminants virus
  80. Peste des Petits Ruminants Infection among Cattle and Wildlife in Northern Tanzania
  81. Early Events following Experimental Infection with Peste-Des-Petits Ruminants Virus Suggest Immune Cell Targeting
  82. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity
  83. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus
  84. Interferon-γ Induced by In Vitro Re-Stimulation of CD4+ T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection
  85. Complete Genome Sequence of a Peste des Petits Ruminants Virus Recovered from Wild Bharal in Tibet, China
  86. A Reliable and Reproducible Experimental Challenge Model for Peste des Petits Ruminants Virus
  87. A novel approach to generating morbillivirus vaccines: Negatively marking the rinderpest vaccine
  88. Field application of a recombinant protein-based ELISA during the 2010 outbreak of foot-and-mouth disease type A in South Korea
  89. Peste des petits ruminants: a suitable candidate for eradication?
  90. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen
  91. Molecular Characterisation of Foot-and-Mouth Disease Viruses from Pakistan, 2005-2008
  92. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control
  93. Vaccines against peste des petits ruminants virus
  94. Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve
  95. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza
  96. The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks
  97. Vaccination against foot-and-mouth disease virus: strategies and effectiveness
  98. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site
  99. Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection
  100. Serological Survey for Foot-and-Mouth Disease Virus in Wildlife in Eastern Africa and Estimation of Test Parameters of a Nonstructural Protein Enzyme-Linked Immunosorbent Assay for Buffalo
  101. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge
  102. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge
  103. Use of a Standardized Bovine Serum Panel To Evaluate a Multiplexed Nonstructural Protein Antibody Assay for Serological Surveillance of Foot-and-Mouth Disease
  104. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine
  105. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies
  106. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus
  107. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle
  108. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex
  109. Importance of the extracellular and cytoplasmic/transmembrane domains of the haemagglutinin protein of rinderpest virus for recovery of viable virus from cDNA copies
  110. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle
  111. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance
  112. Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV
  113. Utility of automated real-time RT-PCR for the detection of foot-and-mouth disease virus excreted in milk
  114. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease
  115. The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes
  116. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx
  117. Sequence analysis of the phosphoprotein gene of peste des petits ruminants (PPR) virus: editing of the gene transcript
  118. Rinderpest virus lineage differentiation using RT-PCR and SNAP-ELISA
  119. Contribution of epidemiological knowledge and control strategies in the eradication of rinderpest virus.